Critical role of p38 mitogen-activated protein kinase signaling in septic lung injury

Critical Care Medicine

Volumn 36, Issue 2, 2008, Pages 482-488

  Asaduzzaman, Muhammad ^a   Wang, Yusheng ^a   Thorlacius, Henrik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chemokines; Leukocytes; Lung; Sepsis; Signaling

Indexed keywords

4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; 6 (4 FLUOROPHENYL) 2,3 DIHYDRO 5 (4 PYRIDYL)IMIDAZO[2,1 B]THIAZOLE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; LEUKOCYTE; LIGATION; LUNG EDEMA; LUNG INFILTRATE; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PUNCTURE; SEPSIS; UNIVERSITY HOSPITAL; WESTERN BLOTTING;

EID: 38549145342     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0B013E31816204FA     Document Type: Article

References (40)

1. Cohen J: The immunopathogenesis of sepsis. Nature 2002; 420:885-891
2. Ware LB, Matthay MA: Clinical practice: Acute pulmonary edema. N Engl J Med 2005; 353:2788-2796
3. Doerschuk CM, Allard MF, Hogg JC: Neutrophil kinetics in rabbits during infusion of zymosan-activated plasma. J Appl Physiol 1989; 67:88-95
4. Doerschuk CM, Allard MF, Martin BA, et al: Marginated pool of neutrophils in rabbit lungs. J Appl Physiol 1987; 63:1806-1815
5. Harlan JM: Leukocyte-endothelial interactions. Blood 1985; 65:513-525
6. Hogg JC, Coxson HO, Brumwell ML, et al: Erythrocyte and polymorphonuclear cell transit time and concentration in human pulmonary capillaries. J Appl Physiol 1994; 77:1795-1800
7. Kuebler WM, Kuhnle GE, Groh J, et al: Leukocyte kinetics in pulmonary microcirculation: Intravital fluorescence microscopic study. J Appl Physiol 1994; 76:65-71
8. Kuhnle GH, Kiefmann R, Sckell A, et al: Leukocyte sequestration in pulmonary microvessels and lung injury following systemic complement activation in rabbits. J Vasc Res 1999; 36:289-298
9. Abraham E, Arcaroli J, Carmody A, et al: HMG-1 as a mediator of acute lung inflammation. J Immunol 2000; 165:2950-2954
10. Guo RF, Ward PA: Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: Insights from the IgG immune complex model. Free Radic Biol Med 2002; 33:303-310
11. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101:3765-3777
12. Rollins BJ: Chemokines. Blood 1997; 90:909-928
13. Bacon KB, Oppenheim JJ: Chemokines in disease models and pathogenesis. Cytokine Growth Factor Rev 1998; 9:167-173
14. Zlotnik A, Morales J, Hedrick JA: Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 1999; 19:1-47
15. Tekamp-Olson P, Gallegos C, Bauer D, et al: Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues. J Exp Med 1990; 172:911-919
16. Oquendo P, Alberta J, Wen DZ, et al: The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platelet alpha-granule proteins. J Biol Chem 1989; 264:4133-4137
17. Reutershan J, Basit A, Galkina EV, et al: Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005; 289:807-815
18. Ropert C, Closel M, Chaves AC, et al: Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages. J Immunol 2003; 171:1456-1465
19. Khan MA, Kang J, Steiner TS: Enteroaggregative Escherichia coli flagellin-induced interleukin-8 secretion requires Toll-like receptor 5-dependent p38 MAP kinase activation. Immunology 2004; 112:651-660
20. Kumar S, Boehm J, Lee JC: p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003; 2:717-726
21. Badger AM, Griswold DE, Kapadia R, et al: Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum 2000; 43:175-183
22. Klintman D, Li X, Santen S, et al: p38 mitogen-activated protein kinase-dependent chemokine production, leukocyte recruitment, and hepatocellular apoptosis in endotoxemic liver injury. Ann Surg 2005; 242:830-839
23. Behr TM, Nerurkar SS, Nelson AH, et al: Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction. Circulation 2001; 104:1292-1298
24. Guo RF, Riedemann NC, Sun L, et al: Divergent signaling pathways in phagocytic cells during sepsis. J Immunol 2006; 177:1306-1313
25. Barone FC, Irving EA, Ray AM, et al: SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther 2001; 296:312-321
26. Johnson LB, Riaz AA, Adawi D, et al: Radiation enteropathy and leucocyte-endothelial cell reactions in a refined small bowel model. BMC Surg 2004; 13:4-10
27. Ma XL, Kumar S, Gao F, et al: Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999; 99:1685-1691
28. Gao F, Yue TL, Shi DW, et al: p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res 2002; 53:414-422
29. Stambe C, Atkins RC, Tesch GH, et al: Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol 2003; 14:338-351
30. Kamochi M, Kamochi F, Kim YB, et al: P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver. Am J Physiol 1999; 277:310-319
31. Gao X, Xu N, Sekosan M, et al: Differential role of CD18 integrins in mediating lung neutrophil sequestration and increased microvascular permeability induced by Escherichia coli in mice. J Immunol 2001; 167:2895-2901
32. Li X, Klintman D, Liu Q, et al: Critical role of CXC chemokines in endotoxemic liver injury in mice. J Leukoc Biol 2004; 75:443-452
33. Feng L, Xia Y, Yoshimura T, et al: Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J Clin Invest 1995; 95:1009-1017
34. Schmal H, Shanley TP, Jones ML, et al: Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol 1996; 156:1963-1972
35. Diab A, Abdalla H, Li HL, et al: Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect Immun 1999; 67:2590 -2601
36. Nick JA, Young SK, Brown KK, et al: Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J Immunol 2000; 164:2151-2159
37. Lomas JL, Chung CS, Grutkoski PS, et al: Differential effects of macrophage inflammatory chemokine-2 and keratinocyte-derived chemokine on hemorrhage-induced neutrophil priming for lung inflammation: Assessment by adoptive cells transfer in mice. Shock 2003; 19:358-365
38. Ayala A, Chung CS, Lomas JL, et al: Shock-induced neutrophil mediated priming for acute lung injury in mice: Divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol 2002; 161:2283-2294
39. Oberholzer A, Oberholzer C, Moldawer LL: Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 2002; 30:58-63
40. Song GY, Chung CS, Chaudry IH, et al: MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis. Am J Physiol Cell Physiol 2001; 281:662-669